Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Margareta Bramnert"'
Autor:
Margareta Bramnert, Thord Rosén, Bertil Ekman, Bengt-Åke Bengtsson, Charlotte Höybye, Helene Holmer, Britt Edén Engström, Marja Thorén, Johan Svensson, Marie Degerblad, Gudmundur Johannsson, Erik Hägg, Eva Marie Erfurth, Lars Rylander
Publikováno v:
Psychoneuroendocrinology. 38:842-852
The psychosocial health and working capacity in hypopituitary patients receiving long-term growth hormone (GH) therapy are unknown.Psychosocial health and levels of employment were compared between GH deficient (GHD) patients on long-term replacement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6fed2c4489ae9f91b191b9c0901ff3
https://doi.org/10.1016/j.psyneuen.2012.09.008
https://doi.org/10.1016/j.psyneuen.2012.09.008
Publikováno v:
Clinical Endocrinology. 40:317-321
Summary OBJECTIVE AND PATIENTS To further explore the difference in plasma noradrenaline in normotensive and hypertensive hypothyroid patients we have investigated the pressor response to exogenous noradrenaline in 11 normotensive and five hypertensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b640a099428d08a690a0ac6f26aa49e6
https://doi.org/10.1111/j.1365-2265.1994.tb03925.x
https://doi.org/10.1111/j.1365-2265.1994.tb03925.x
Autor:
Britt Edén Engström, Bertil Ekman, Johan Svensson, Eva Marie Erfurth, Marja Thorén, Charlotte Höybye, Marie Degerblad, Thord Rosén, Lars Rylander, Bo Norrving, Erik Hägg, Helene Holmer, Gudmundur Johannsson, Margareta Bramnert, Bengt-Åke Bengtsson, Lars Hagmar
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 92:3560-3567
The impact of long-term GH replacement on cerebrovascular and cardiovascular diseases and diabetes mellitus in hypopituitary patients is unknown.The incidence of nonfatal stroke and cardiac events, and prevalence of type 2 diabetes mellitus (T2D) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1ed2e21e5d10ae089a99217668013c
https://doi.org/10.1210/jc.2007-0458
https://doi.org/10.1210/jc.2007-0458
Autor:
Marja Thorén, Thord Rosén, Marie Degerblad, Lars Hagmar, Bertil Ekman, Bengt-Åke Bengtsson, Helene Holmer, Britt Edén Engström, Gudmundur Johannsson, Johan Svensson, Lars Rylander, Eva Marie Erfurth, Margareta Bramnert, Charlotte Höybye, Karl-Göran Thorngren, Erik Hägg
Publikováno v:
Journal of Bone and Mineral Research. 22:1842-1850
Fracture risk in GHD patients is not definitely established. Studying fracture incidence in 832 patients on GH therapy and 2581 matched population controls, we recorded a doubled fracture risk in CO GHD women, but a significantly lower fracture risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33443ccf3bf687546160a414f50b04a2
https://doi.org/10.1359/jbmr.070811
https://doi.org/10.1359/jbmr.070811
Autor:
Nadine Binart, Jon Kindblom, Paul A. Kelly, Margareta Bramnert, Louise Nilsson, Emil Egecioglu, Charlotte Ling, Håkan Billig, Christopher J. Ormandy, John J. Kopchick, Mohammad Bohlooly-Y
Publikováno v:
Biochemical and Biophysical Research Communications. 331:1120-1126
Adiponectin is a hormone secreted from adipose tissue, and serum levels are decreased with obesity and insulin resistance. Because prolactin (PRL) and growth hormone (GH) can affect insulin sensitivity, we investigated the effects of these hormones o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::781cdfcd34a1624db2b5277d6b6aa536
https://doi.org/10.1016/j.bbrc.2005.04.026
https://doi.org/10.1016/j.bbrc.2005.04.026
Publikováno v:
Hormone Research in Paediatrics. 64:45-50
Adult growth hormone deficiency (GHD) is a multifactorial disorder in which pituitary dysfunction associated with pituitary adenomas or their treatment plays a major role. The introduction of recombinant growth hormone (GH) for the treatment of GHD h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa8ce494d5376f60694f1392571ff641
https://doi.org/10.1159/000089317
https://doi.org/10.1159/000089317
Publikováno v:
European Journal of Endocrinology. :701-707
OBJECTIVE: Insulin resistance is a frequent consequence of GH replacement therapy but patients on GH replacement therapy often also have replacement of other hormone deficiencies which theoretically could modify the metabolic effects of GH. In partic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4589026f3cdb88a6cc33622a97c9fd7
https://doi.org/10.1530/eje.0.1510701
https://doi.org/10.1530/eje.0.1510701
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 88:1455-1463
The effects of GH replacement therapy on energy metabolism are still uncertain, and long-term benefits of increased muscle mass are thought to outweigh short-term negative metabolic effects. This study was designed to address this issue by examining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f36164a369a87e59387ce2969d8761
https://doi.org/10.1210/jc.2002-020542
https://doi.org/10.1210/jc.2002-020542
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:5813-5818
To test the hypothesis that GH-induced insulin resistance is mediated by an increase in FFA levels we assessed insulin sensitivity after inhibiting the increase in FFA by a nicotine acid derivative, Acipimox, in nine GH-deficient adults receiving GH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f52e06f10f6059c7fe52f32e631a0cd5
https://doi.org/10.1210/jcem.86.12.8096
https://doi.org/10.1210/jcem.86.12.8096
Publikováno v:
Growth Hormone & IGF Research. 11:273-281
The safety and effects of a fixed low dose of growth hormone (GH), 0.17 mg/day was evaluated for 3 months, on glucose metabolism, serum lipids, body composition and cardiac function in 53 GH deficient adults aged 18-78 years. Body composition was det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e6af01bbc7ac565feb3c4529873a09a
https://doi.org/10.1054/ghir.2001.0240
https://doi.org/10.1054/ghir.2001.0240